Ann: Sale of French Subsidiaries to Domain Therapeutics, page-10

I know that I am being just impatient but the last meaningful update was the FDA "fast track" announcement on the 4th November - and I do realise that this process takes time.

Other than the usual AGN presentation, BNO appears to offer no information to its shareholders. I accept that it is prudent not to have too much commentary about the FDA while the process is running, but leaving SH in perpetual ignorance of what is going on is why the SP continues to languish.